Sarepta Therapeutics (AB3A) Q3 2024 Earnings Report
CH:AB3A Q3 2024 EPS Results
- Actual EPS
- CHF 0.28
- Consensus EPS
- -CHF 0.06
- Beat/Miss
- Beat by +CHF 0.34
- One Year Ago EPS
- -CHF 0.38
CH:AB3A Q3 2024 Revenue Results
- Actual Revenue
- CHF 382.96M
- Expected Revenue
- CHF 333.77M
- Beat/Miss
- Beat by +CHF 49.18M
- YoY Revenue Growth
- +40.79%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/06/2024
- Time
- After Close
- Conference Call
- Wednesday, November 6, 2024
CH:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
CH:AB3A Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 0.06- | -1.48 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 0.18-0.04 | 1.55 | -102.65% (-1.59) | |
| May 06, 2026 | 2026 (Q1) | 0.802.36 | -3.77 | 162.61% (+6.13) | |
| Feb 25, 2026 | 2025 (Q4) | -0.98-3.22 | 1.23 | -362.00% (-4.45) | |
| Nov 03, 2025 | 2025 (Q3) | -0.60-1.48 | 0.28 | -629.41% (-1.75) | |
| Aug 06, 2025 | 2025 (Q2) | 0.681.55 | 0.06 | 2600.00% (+1.49) | |
| May 06, 2025 | 2025 (Q1) | -2.63-3.77 | 0.3 | -1343.24% (-4.07) | |
| Feb 26, 2025 | 2024 (Q4) | 1.541.23 | 0.39 | 219.15% (+0.84) | |
| Nov 06, 2024 | 2024 (Q3) | -0.060.28 | -0.38 | 173.91% (+0.66) | |
| Aug 07, 2024 | 2024 (Q2) | -0.110.06 | -0.22 | 125.93% (+0.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
